Cargando…

Selection of Nanobodies that Target Human Neonatal Fc Receptor

FcRn is a key player in several immunological and non-immunological processes, as it mediates maternal-fetal transfer of IgG, regulates the serum persistence of IgG and albumin, and transports both ligands between different cellular compartments. In addition, FcRn enhances antigen presentation. Thus...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen, Jan Terje, Gonzalez-Pajuelo, Maria, Foss, Stian, Landsverk, Ole J. B., Pinto, Débora, Szyroki, Alexander, de Haard, Hans J., Saunders, Michael, Vanlandschoot, Peter, Sandlie, Inger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552320/
https://www.ncbi.nlm.nih.gov/pubmed/23346375
http://dx.doi.org/10.1038/srep01118
_version_ 1782256662765109248
author Andersen, Jan Terje
Gonzalez-Pajuelo, Maria
Foss, Stian
Landsverk, Ole J. B.
Pinto, Débora
Szyroki, Alexander
de Haard, Hans J.
Saunders, Michael
Vanlandschoot, Peter
Sandlie, Inger
author_facet Andersen, Jan Terje
Gonzalez-Pajuelo, Maria
Foss, Stian
Landsverk, Ole J. B.
Pinto, Débora
Szyroki, Alexander
de Haard, Hans J.
Saunders, Michael
Vanlandschoot, Peter
Sandlie, Inger
author_sort Andersen, Jan Terje
collection PubMed
description FcRn is a key player in several immunological and non-immunological processes, as it mediates maternal-fetal transfer of IgG, regulates the serum persistence of IgG and albumin, and transports both ligands between different cellular compartments. In addition, FcRn enhances antigen presentation. Thus, there is an intense interest in studies of how FcRn binds and transports its cargo within and across several types of cells, and FcRn detection reagents are in high demand. Here we report on phage display-selected Nanobodies that target human FcRn. The Nanobodies were obtained from a variable-domain repertoire library isolated from a llama immunized with recombinant human FcRn. One candidate, Nb218-H4, was shown to bind FcRn with high affinity at both acidic and neutral pH, without competing ligand binding and interfering with FcRn functions, such as transcytosis of IgG. Thus, Nb218-H4 can be used as a detection probe and as a tracker for visualization of FcRn-mediated cellular transport.
format Online
Article
Text
id pubmed-3552320
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-35523202013-01-23 Selection of Nanobodies that Target Human Neonatal Fc Receptor Andersen, Jan Terje Gonzalez-Pajuelo, Maria Foss, Stian Landsverk, Ole J. B. Pinto, Débora Szyroki, Alexander de Haard, Hans J. Saunders, Michael Vanlandschoot, Peter Sandlie, Inger Sci Rep Article FcRn is a key player in several immunological and non-immunological processes, as it mediates maternal-fetal transfer of IgG, regulates the serum persistence of IgG and albumin, and transports both ligands between different cellular compartments. In addition, FcRn enhances antigen presentation. Thus, there is an intense interest in studies of how FcRn binds and transports its cargo within and across several types of cells, and FcRn detection reagents are in high demand. Here we report on phage display-selected Nanobodies that target human FcRn. The Nanobodies were obtained from a variable-domain repertoire library isolated from a llama immunized with recombinant human FcRn. One candidate, Nb218-H4, was shown to bind FcRn with high affinity at both acidic and neutral pH, without competing ligand binding and interfering with FcRn functions, such as transcytosis of IgG. Thus, Nb218-H4 can be used as a detection probe and as a tracker for visualization of FcRn-mediated cellular transport. Nature Publishing Group 2013-01-23 /pmc/articles/PMC3552320/ /pubmed/23346375 http://dx.doi.org/10.1038/srep01118 Text en Copyright © 2013, Macmillan Publishers Limited. All rights reserved http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Article
Andersen, Jan Terje
Gonzalez-Pajuelo, Maria
Foss, Stian
Landsverk, Ole J. B.
Pinto, Débora
Szyroki, Alexander
de Haard, Hans J.
Saunders, Michael
Vanlandschoot, Peter
Sandlie, Inger
Selection of Nanobodies that Target Human Neonatal Fc Receptor
title Selection of Nanobodies that Target Human Neonatal Fc Receptor
title_full Selection of Nanobodies that Target Human Neonatal Fc Receptor
title_fullStr Selection of Nanobodies that Target Human Neonatal Fc Receptor
title_full_unstemmed Selection of Nanobodies that Target Human Neonatal Fc Receptor
title_short Selection of Nanobodies that Target Human Neonatal Fc Receptor
title_sort selection of nanobodies that target human neonatal fc receptor
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552320/
https://www.ncbi.nlm.nih.gov/pubmed/23346375
http://dx.doi.org/10.1038/srep01118
work_keys_str_mv AT andersenjanterje selectionofnanobodiesthattargethumanneonatalfcreceptor
AT gonzalezpajuelomaria selectionofnanobodiesthattargethumanneonatalfcreceptor
AT fossstian selectionofnanobodiesthattargethumanneonatalfcreceptor
AT landsverkolejb selectionofnanobodiesthattargethumanneonatalfcreceptor
AT pintodebora selectionofnanobodiesthattargethumanneonatalfcreceptor
AT szyrokialexander selectionofnanobodiesthattargethumanneonatalfcreceptor
AT dehaardhansj selectionofnanobodiesthattargethumanneonatalfcreceptor
AT saundersmichael selectionofnanobodiesthattargethumanneonatalfcreceptor
AT vanlandschootpeter selectionofnanobodiesthattargethumanneonatalfcreceptor
AT sandlieinger selectionofnanobodiesthattargethumanneonatalfcreceptor